- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12:42 | Tecentriq wins FDA priority review for certain early NSCLC patients | ||
| 11:42 | Gov't launches study on COVID-19 vaccine dose interval for pregnant women | ||
| 10:42 | Sanofi boosts its mRNA capabilities with Translate Bio acquisition | ||
| Mo | AZ's Saphnelo scores US approval for systemic lupus erythematosus | ||
| Mo | EC approves BMS' Opdivo as adjuvant treatment for oesophageal or GEJ cancer patients | ||
| Mo | UCB's bimekizumab issued NICE recommendation for severe plaque psoriasis | ||
| Mo | More than 85 million COVID vaccines administered across the UK, reports DHSC | ||
| Fr | NICE publishes 'rapid' guideline on rare blood clots associated with COVID-19 jab | ||
| Fr | GSK's Nucala approved to treat chronic rhinosinusitis with nasal polyps | ||
| Fr | UK genomics market valued at over £5bn, according to new report | ||
| Fr | GPs call for rescue plan to 'save' general practice in the UK | ||
| Do | Ipsen to collaborate with BAKX Therapeutics on early-stage oncology asset | ||
| Do | Sanofi, Regeneron's Dupixent wins positive results in chronic spontaneous urticaria | ||
| Do | Macomics secures £4.24m to accelerate macrophage-based therapeutics portfolio | ||
| Do | New study provides insight into the pharma industry's reputation in the UK | ||
| Mi | Early data shows CanSinoBIO's inhaled COVID-19 vaccine triggers immune response | ||
| Mi | Study shows AZ's COVID-19 jab did not increase the rate of rare blood clots after second dose | ||
| Mi | AC Immune acquires Parkinson's disease vaccine candidate | ||
| Mi | Regeneron, AZ partner on development of novel obesity drugs | ||
| 27.07. | NICE publishes new draft guideline covering rehabilitation after traumatic injury | ||
| 27.07. | EU backs approval of Moderna's COVID-19 vaccine in 12-17 year-olds | ||
| 27.07. | Organon and ObsEva to collaborate on preterm labour treatment | ||
| 27.07. | BioNTech to develop a mRNA-based malaria vaccine | ||
| 26.07. | Four-drug combo therapy shows benefit for newly-diagnosed myeloma patients | ||
| 26.07. | Researchers find extending the time between Pfizer doses boosts antibodies |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
